1 – 5 of 48
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer
(
- Contribution to journal › Article
-
Mark
Delineating the intra-patient heterogeneity of molecular alterations in treatment-naïve colorectal cancer with peritoneal carcinomatosis
(
- Contribution to journal › Article
-
Mark
Branching copy number evolution and parallel immune profiles across the regional tumor space of resected pancreatic cancer
(
- Contribution to journal › Article
- 2021
-
Mark
Clinical significance of RBM3 expression in surgically treated colorectal lung metastases and paired primary tumours
(
- Contribution to journal › Article
- 2020
-
Mark
Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas
(
- Contribution to journal › Article